Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule

Arbo, Antonio; Falleiros-Arlant, Luiza Helena; López, Eduardo L; Brea del Castillo, José; Martínez de Cuellar, Celia; Moreno, Gabriela; Rolón, Roger; Cerda, Javier; Eguiazú, Salim.
Rev. chil. infectol ; 36(1): 83-90, feb. 2019. tab
Artigo em Inglês | LILACS | ID: biblio-1003656

Documentos relacionados

  1. Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule.
  2. 3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities. A webinar and workshop report.
  3. Characterisation of diphtheria monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
  4. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
  5. Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.
  6. Sabin Strain Inactivated Polio Vaccine for the Polio Endgame.
  7. Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution - Part 2.
  8. Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines in a Schedule Without a Booster Dose: A 10-Year Observational Study.
  9. Research progress on substitution of <i>in vivo</i> method(s) by <i>in vitro</i> method(s) for human vaccine potency assays.
  10. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.